FDA Turns Kratom's Future In US Dietary Supplement Market Into History
This article was originally published in The Rose Sheet
Executive Summary
FDA Commissioner Scott Gottlieb says kratom's apparently increasing use "as an alternative or adjunct to opioid use" has made enforcement on the ingredient more of a priority for FDA, and "given the scope of this crisis, we must do more."